Cytek Biosciences (CTKB) Acquisitions (2023 - 2024)
Cytek Biosciences posted quarterly Acquisitions of $471000.0 for Q4 2024, up 47000.0% on a QoQ basis from $1000.0 in Q3 2023.
Cytek Biosciences (CTKB) has 2 years of Acquisitions data on file, last reported at $471000.0 in Q4 2024.
- For the quarter ending Q4 2024, Acquisitions changed N/A year-over-year to $471000.0; the trailing twelve-month figure through Dec 2024 stood at $471000.0 (down 98.95% YoY), and the FY2024 full-year result was $471000.0, down 98.95% from the prior year.
- Acquisitions for Q4 2024 stood at $471000.0, up from $1000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $44.9 million in Q1 2023 and bottomed at $1000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 471,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 44.90 Mn |